Physician profile
Patrick Waters
NPI 1720084718
$492.26
in general payments reported to CMS, 2019-2025
12 companies · $39.88 in 2025
The $39.88 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.28 · 2020: $206 · 2021: $27.62 · 2022: $98.45 · 2023: $39.46 · 2024: $23.42 · 2025: $39.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $101.96 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $90.92 | 2020 | |
| Abbvie INC. | $82.96 | 2022-2025 | |
| Boston Scientific Corporation | $42.56 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $30.23 | 2019-2020 | |
| Medline Industries Lp | $27.62 | 2021 | |
| Laborie Medical Technologies Corp. | $24.42 | 2025 | |
| Antares Pharma, INC. | $23.94 | 2023 | Nocdurna, Tlando, Xyosted |
| Procept Biorobotics Corporation | $23.42 | 2024 | Aquabeam System |
| Medtronic, INC. | $15.71 | 2022 | |
| Convatec INC. | $15.52 | 2023 | |
| Allergan, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.